Dr. Jacqueline Jeruss

Bio

Dr. Jeruss received her medical degree from the University of Vermont. She completed her general surgery residency training at Northwestern University Feinberg School of Medicine and holds a Ph.D. from Northwestern, having completed her dissertation in the field of breast cancer biology. She completed her fellowship in breast surgical oncology at M.D. Anderson Cancer Center and returned to Northwestern as an Associate Professor of Surgery in the Division of Breast Surgery before joining the University of Michigan faculty.

Treatment of Aggressive Subtypes

Dr. Jeruss’ clinical and basic research interests focus on novel therapeutics for aggressive breast cancer subtypes, new approaches to manage cancer metastasis, incorporation of fertility preservation into the care of young patients with cancer, and surgical ethics. Her research efforts, to date, have yielded new insights into the mechanisms associated with breast cancer cell cycle deregulations and the implementation of bioengineered scaffolds to forestall breast cancer metastasis.

 

Her research program is funded by the National Institutes of Health and she credits support from The Lynn Sage Foundation for preparing her for this prestigious funding. Dr. Jeruss was also the recipient of the Society of Surgical Oncology Clinical Investigator Award in Breast Cancer that supported the preclinical work for a study directed toward the treatment of patients with hormone receptor negative breast cancer.

Dr. Jacqueline Jeruss

University of Michigan

News & Articles

3 Chicago Hospitals Team Up to Fight Breast Cancer in New Clinical Trial

Top Chicago Hospitals Join Forces in the Chicago Breast Cancer Research Consortium

Three Chicago Hospitals Collaborate on Breast Cancer Clinical Trial

Meet Our Other Scholars

Newly funded researchers pursuing high-risk, high-reward breast cancer studies in their first or second academic positions.

Abde Abukhdeir, PhD headshot

Past

Early Investigator

Abde Abukhdeir, PhD

The molecular variants that lead or contribute to drug resistance in breast cancer

Dr. Nan Chen

Past

Early Investigator

Nan Chen, MD

Discovering novel biomarkers of therapy response and resistance in metastatic triple-negative breast cancer patients

Peiwen Chen, PhD headshot

Past

Early Investigator

Peiwen Chen, PhD

Targeting macrophage reprogramming in brain metastatic breast cancer

Why your gift matters

Every scholar funded is a future breakthrough made possible

Your gift helps researchers test bold ideas, generate critical data, and take the first steps toward the next major advancement in breast cancer treatment and care.Together, we can accelerate discoveries that save lives.

Contact Us

Email info@lynnsage.org
Contact Form (#6)